Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fragile X targeted pharmacotherapy: lessons learned and future directions.
Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, Fitzpatrick SE, Brown WT, Budimirovic D, Hagerman RJ, Hessl D, Kaufmann WE, Berry-Kravis E. Erickson CA, et al. Among authors: wink lk. J Neurodev Disord. 2017 Jun 12;9:7. doi: 10.1186/s11689-017-9186-9. eCollection 2017. J Neurodev Disord. 2017. PMID: 28616096 Free PMC article. Review.
Risperidone Treatment for Irritability in Fragile X Syndrome.
Dominick KC, Wink LK, Pedapati EV, Shaffer R, Sweeney JA, Erickson CA. Dominick KC, et al. Among authors: wink lk. J Child Adolesc Psychopharmacol. 2018 May;28(4):274-278. doi: 10.1089/cap.2017.0057. Epub 2018 Feb 2. J Child Adolesc Psychopharmacol. 2018. PMID: 29394101
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis.
Eckert EM, Dominick KC, Pedapati EV, Wink LK, Shaffer RC, Andrews H, Choo TH, Chen C, Kaufmann WE, Tartaglia N, Berry-Kravis EM, Erickson CA. Eckert EM, et al. Among authors: wink lk. J Autism Dev Disord. 2019 Nov;49(11):4595-4602. doi: 10.1007/s10803-019-04173-z. J Autism Dev Disord. 2019. PMID: 31468273 Free PMC article.
Pediatric Quality of Life Inventory (PedsQL) in Fragile X Syndrome.
Fitzpatrick SE, Schmitt LM, Adams R, Pedapati EV, Wink LK, Shaffer RC, Sage J, Weber JD, Dominick KC, Erickson CA. Fitzpatrick SE, et al. Among authors: wink lk. J Autism Dev Disord. 2020 Mar;50(3):1056-1063. doi: 10.1007/s10803-019-04292-7. J Autism Dev Disord. 2020. PMID: 31728808 Free PMC article.
Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker.
Erickson CA, Ray B, Maloney B, Wink LK, Bowers K, Schaefer TL, McDougle CJ, Sokol DK, Lahiri DK. Erickson CA, et al. Among authors: wink lk. J Psychiatr Res. 2014 Dec;59:220-8. doi: 10.1016/j.jpsychires.2014.07.011. Epub 2014 Aug 19. J Psychiatr Res. 2014. PMID: 25300441 Free PMC article.
Analysis of peripheral amyloid precursor protein in Angelman Syndrome.
Erickson CA, Wink LK, Baindu B, Ray B, Schaefer TL, Pedapati EV, Lahiri DK. Erickson CA, et al. Among authors: wink lk. Am J Med Genet A. 2016 Sep;170(9):2334-7. doi: 10.1002/ajmg.a.37811. Epub 2016 Jun 21. Am J Med Genet A. 2016. PMID: 27327493
48 results